Core Scientific, Inc.
CORZ
$19.55
-$0.24-1.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 289.07M | 162.61M | 89.81M | 67.24M | 70.79M |
| Total Other Revenue | 151.24M | 192.13M | 229.21M | 266.94M | 277.64M |
| Total Revenue | 440.31M | 354.74M | 319.02M | 334.18M | 348.43M |
| Cost of Revenue | 298.81M | 278.26M | 264.43M | 299.66M | 317.98M |
| Gross Profit | 141.50M | 76.48M | 54.59M | 34.52M | 30.46M |
| SG&A Expenses | 196.80M | 192.70M | 180.41M | 184.49M | 160.99M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 66.64M | 27.47M | 31.60M | -26.50M | -15.34M |
| Total Operating Expenses | 562.25M | 498.43M | 476.44M | 457.65M | 463.63M |
| Operating Income | -121.94M | -143.69M | -157.42M | -123.47M | -115.20M |
| Income Before Tax | -1.43B | -1.22B | -292.48M | -894.76M | -1.20B |
| Income Tax Expenses | 2.73M | 978.00K | 583.00K | 863.00K | 872.00K |
| Earnings from Continuing Operations | -1.44K | -1.22K | -293.06 | -895.62 | -1.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.44B | -1.22B | -293.06M | -895.62M | -1.20B |
| EBIT | -121.94M | -143.69M | -157.42M | -123.47M | -115.20M |
| EBITDA | -59.37M | -77.86M | -88.51M | -42.61M | -21.98M |
| EPS Basic | -4.26 | -0.97 | -0.10 | -1.69 | -2.41 |
| Normalized Basic EPS | -1.86 | -1.64 | -0.36 | -1.40 | -2.12 |
| EPS Diluted | -4.44 | -1.16 | -0.28 | -1.69 | -2.41 |
| Normalized Diluted EPS | -2.03 | -1.80 | -0.52 | -1.40 | -2.12 |
| Average Basic Shares Outstanding | 1.29B | 1.28B | 1.27B | 1.26B | 1.23B |
| Average Diluted Shares Outstanding | 1.43B | 1.42B | 1.42B | 1.26B | 1.23B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |